GL1X · GenesisL1 explorer

MolNFT v1 · #123741 · protein

5JTJ: USP7CD-CTP in complex with ubiquitin

5JTJ · Ubiquitin carboxyl-terminal hydrolase 7,UBIQUITIN carboxyl…: “USP7CD-CTP in complex with ubiquitin”. X-ray diffraction, 1 ligand (CA), 6 pockets (best druggability 0.52). MolNFT v1 #123741 on GenesisL1: 3D structure, binding sites…

3D structure of 5JTJ: USP7CD-CTP in complex with ubiquitin (MolNFT v1 / PDB)
3D structure of 5JTJ: USP7CD-CTP in complex with ubiquitin (MolNFT v1 / PDB)
PDB
5JTJ
Type
protein
Length
432 residues
Chains
2
Method
x-ray diffraction
Deposited
09-MAY-16
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ubiquitin carboxyl-terminal hydrolase 7,UBIQUITIN carboxyl- terminal hydrolase 7…
EC
3.4.19.12
UniProt
Q93009, P0CG47
Ligands
CA
Pockets
6 · best druggability 0.52

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUbiquitin carboxyl-terminal hydrolase 7,UBIQUITIN carboxyl- terminal hydrolase 7 (EC 3.4.19.12)protein35631% helix, 28% strandQ93009
BPolyubiquitin-Bprotein7616% helix, 30% strandP0CG47

Ligands and binding sites

  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11360.520.8122empty
21080.400.7626empty
3830.350.768empty
4670.350.7714empty
5750.350.7616empty

Interfaces

1 interface between chains.

  • A–B · 1862 Ų buried · 33 hydrogen bonds · protein-protein

Compared structures

  • 5JTJ · USP7CD-CTP in complex with Ubiquitin · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

Other records of 5JTJ

  • 5JTJ · MolNFT v2 / PDB Bank · USP7CD-CTP in complex with Ubiquitin

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.